Haslam K - Search Results

1

Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.

Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E. Langabeer SE, et al. Among authors: haslam k. Acta Haematol. 2011;126(4):214-5. doi: 10.1159/000330956. Epub 2011 Sep 16. Acta Haematol. 2011. PMID: 21934295 No abstract available.

2

Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.

McCarron SL, Langabeer SE, Bolger K, Haslam K, Crampe M, Kelly J, Morrell R. McCarron SL, et al. Among authors: haslam k. Med Oncol. 2015 Feb;32(2):452. doi: 10.1007/s12032-014-0452-3. Epub 2015 Jan 13. Med Oncol. 2015. PMID: 25579165

3

Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.

Crampe M, Haslam K, Kelly J, Conneally E, Langabeer SE. Crampe M, et al. Among authors: haslam k. Hematol Oncol Stem Cell Ther. 2017 Jun;10(2):85-88. doi: 10.1016/j.hemonc.2016.02.002. Epub 2016 Mar 17. Hematol Oncol Stem Cell Ther. 2017. PMID: 27013275 Free article.

4

Incidence and significance of FLT3-ITD and NPM1 mutations in patients with normal karyotype acute myeloid leukaemia.

Haslam K, Chadwick N, Kelly J, Browne P, Vandenberghe E, Flynn C, Conneally E, Langabeer SE. Haslam K, et al. Ir J Med Sci. 2010 Dec;179(4):507-10. doi: 10.1007/s11845-010-0567-2. Epub 2010 Aug 31. Ir J Med Sci. 2010. PMID: 20803351

5

A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia.

McCarron SL, Haslam K, Kelly J, Duggan C, Langabeer SE. McCarron SL, et al. Among authors: haslam k. Int J Lab Hematol. 2012 Feb;34(1):e1-2. doi: 10.1111/j.1751-553X.2011.01346.x. Epub 2011 Jun 22. Int J Lab Hematol. 2012. PMID: 21692997 No abstract available.

6

Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia.

Langabeer SE, Haslam K, Crampe M, MacDonagh B, McHugh J. Langabeer SE, et al. Among authors: haslam k. Exp Oncol. 2019 Mar;41(1):82-83. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-1.12685. Exp Oncol. 2019. PMID: 30932408 No abstract available.

7

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia.

Haslam K, Langabeer SE, Kelly J, Coen N, O'Connell NM, Conneally E. Haslam K, et al. Case Rep Hematol. 2012;2012:620967. doi: 10.1155/2012/620967. Epub 2012 Oct 2. Case Rep Hematol. 2012. PMID: 23082258 Free PMC article.

8

Lack of myeloproliferative neoplasm-associated CALR mutations in acute promyelocytic leukemia.

Langabeer SE, Haslam K. Langabeer SE, et al. Among authors: haslam k. Leuk Lymphoma. 2015 Apr;56(4):1168-9. doi: 10.3109/10428194.2014.953156. Epub 2014 Oct 7. Leuk Lymphoma. 2015. PMID: 25115510 No abstract available.

9

Incidence of CALR mutations in patients with splanchnic vein thrombosis.

Haslam K, Langabeer SE. Haslam K, et al. Br J Haematol. 2015 Feb;168(3):459-60. doi: 10.1111/bjh.13121. Epub 2014 Sep 16. Br J Haematol. 2015. PMID: 25223992 Free article. No abstract available.

10

Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia.

Haslam K, Langabeer SE, Hayat A, Conneally E, Vandenberghe E. Haslam K, et al. Br J Haematol. 2016 Oct;175(1):161-3. doi: 10.1111/bjh.13838. Epub 2015 Nov 3. Br J Haematol. 2016. PMID: 26525156 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters